首页 > 最新文献
paperpass

Elsevier最新文献

英文 中文
IF:
The spatiotemporal-specific regulation of cell wall-related proteins promotes the secretion of pigments in Antarctic fungi Geomyces sp. wnf-18c. 南极真菌Geomyces sp. wnf-18c细胞壁相关蛋白的时空特异性调控促进了色素的分泌。
IF 8.2 1区 环境科学与生态学 Q1 AGRICULTURAL ENGINEERING Pub Date : 2026-12-01 Epub Date: 2026-08-16 DOI: 10.1016/j.biortech.2026.135614
Jiawen Du, Long Liu, Jiawen Gao, Xiaofeng Zhu, Lingkai Kong, Ting Cui, Menghao Cai, Xuemei Li, Yunxia Zhao, Xinyu Lu, Nengfei Wang, Shusheng Zhang

The polar environment harbors extremely rich and valuable natural product resources. In this study, a strain of Antarctic fungus, Geomyces sp. wnf-18c, in Antarctic soil was isolated in a laboratory. This fungus produces a purplish-red pigment whose hue closely resembles that of the high-end pigment carminic acid. However, approximately 50 % of the pigment remains within the fungal hyphae, restricting subsequent separation and extraction. In this study, the deletion of the key cell wall protein-encoding genes CHS3 and AGS1 enhanced pigment secretion. It also considerably inhibited the strain's growth, making it difficult to substantially increase the total pigment yield. To overcome these hurdles, the xylose-inducible system from Trichoderma reesei was heterologously expressed in Antarctic fungi, and the CRISPR-Cas9 system was placed under the control of this induction system. The exogenous addition of xylose as a signal to initiate genetic editing achieved the spatiotemporal regulation of the target gene-activating gene editing that restricts growth only after the completion of the strain's growth phase. The spatiotemporal regulation of key cell wall proteins significantly mitigated growth inhibition, greatly enhanced pigment secretion, and raised the total pigment yield. This discovery advances our understanding of the spatiotemporal specificity and dynamic regulation of microorganisms, offering novel strategies for exploiting polar microbial resources and reducing industrial production costs.

极地环境蕴藏着极其丰富和宝贵的自然产物资源。本研究在实验室中从南极土壤中分离出一株南极真菌,Geomyces sp. wnf-18c。这种真菌产生一种紫红色的色素,其色调与高端色素胭脂红酸非常相似。然而,大约50% %的色素留在真菌菌丝内,限制了随后的分离和提取。在本研究中,细胞壁蛋白编码关键基因CHS3和AGS1的缺失增加了色素的分泌。它也大大抑制了菌株的生长,使其难以大幅提高总色素产量。为了克服这些障碍,我们将里氏木霉木糖诱导系统在南极真菌中异源表达,并将CRISPR-Cas9系统置于该诱导系统的控制下。外源添加木糖作为启动基因编辑的信号,实现了对目标基因激活基因编辑的时空调控,只有在菌株生长阶段完成后才能限制生长。关键细胞壁蛋白的时空调控显著减轻了生长抑制,大大增强了色素分泌,提高了总色素产量。这一发现促进了我们对微生物时空特异性和动态调控的理解,为开发极地微生物资源和降低工业生产成本提供了新的策略。
{"title":"The spatiotemporal-specific regulation of cell wall-related proteins promotes the secretion of pigments in Antarctic fungi Geomyces sp. wnf-18c.","authors":"Jiawen Du, Long Liu, Jiawen Gao, Xiaofeng Zhu, Lingkai Kong, Ting Cui, Menghao Cai, Xuemei Li, Yunxia Zhao, Xinyu Lu, Nengfei Wang, Shusheng Zhang","doi":"10.1016/j.biortech.2026.135614","DOIUrl":"10.1016/j.biortech.2026.135614","url":null,"abstract":"<p><p>The polar environment harbors extremely rich and valuable natural product resources. In this study, a strain of Antarctic fungus, Geomyces sp. wnf-18c, in Antarctic soil was isolated in a laboratory. This fungus produces a purplish-red pigment whose hue closely resembles that of the high-end pigment carminic acid. However, approximately 50 % of the pigment remains within the fungal hyphae, restricting subsequent separation and extraction. In this study, the deletion of the key cell wall protein-encoding genes CHS3 and AGS1 enhanced pigment secretion. It also considerably inhibited the strain's growth, making it difficult to substantially increase the total pigment yield. To overcome these hurdles, the xylose-inducible system from Trichoderma reesei was heterologously expressed in Antarctic fungi, and the CRISPR-Cas9 system was placed under the control of this induction system. The exogenous addition of xylose as a signal to initiate genetic editing achieved the spatiotemporal regulation of the target gene-activating gene editing that restricts growth only after the completion of the strain's growth phase. The spatiotemporal regulation of key cell wall proteins significantly mitigated growth inhibition, greatly enhanced pigment secretion, and raised the total pigment yield. This discovery advances our understanding of the spatiotemporal specificity and dynamic regulation of microorganisms, offering novel strategies for exploiting polar microbial resources and reducing industrial production costs.</p>","PeriodicalId":258,"journal":{"name":"Bioresource Technology","volume":" ","pages":"135614"},"PeriodicalIF":8.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148760457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remission outcomes with bupropion versus selective serotonin reuptake inhibitors in major depressive disorder with comorbid obesity: A propensity-matched cohort analysis. 安非他酮与选择性血清素再摄取抑制剂单药治疗合并肥胖的重度抑郁症的缓解结果:一项倾向匹配的队列分析。
IF 5.7 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-12-01 Epub Date: 2026-08-20 DOI: 10.1016/j.jad.2026.122398
Farah Khorassani, Justin Schneider, Jonathan Prunean, Gemma Espejo

Observational and secondary analyses of clinical trials evaluating efficacy of antidepressants suggest that medications with noradrenergic and dopaminergic mechanisms of action may be more effective in managing symptoms of major depressive disorder (MDD) in obese patients than medications that are purely serotonergic. The purpose of this study is to compare the efficacy of bupropion versus SSRIs in patients without a documented antidepressant trial with comorbid MDD and obesity. This was a retrospective, propensity-score matched, observational study utilizing a global cohort within the TriNetX database. Adults aged 18 or over with a major depressive episode and obesity were grouped into two cohorts: 1) exposure to bupropion and 2) exposure to SSRIs. Patients with antidepressant exposure prior to the index event were excluded. Both cohorts were propensity matched based on 16 covariates. The primary outcome was remission of a major depressive episode. Secondary outcomes included evaluating socioeconomic and psychosocial differences between the groups. Each cohort yielded 165,629 patients. The primary endpoint analysis indicated a small but statistically significant difference in MDD remission rates in favor of bupropion with an absolute risk rate of 8.5% compared to 7.9% in the SSRI group (Risk Ratio [RR] 1.07, 95% CI 1.05-1.10, p < 0.0001). Binary outcomes were summarized using risk differences and risk ratios and compared between cohorts using chi-square tests. Our findings suggest bupropion monotherapy was associated with a small but statistically significant higher remission rate compared with SSRIs but further prospective studies using objective remission indicators are needed.

对评估抗抑郁药物疗效的临床试验的观察和二次分析表明,具有去甲肾上腺素能和多巴胺能作用机制的药物在治疗肥胖患者的重度抑郁症(MDD)症状方面可能比纯血清素能药物更有效。本研究的目的是比较安非他酮与SSRIs在无抗抑郁试验记录的伴有重度抑郁症和肥胖的患者中的疗效。这是一项回顾性、倾向评分匹配的观察性研究,利用TriNetX数据库中的全球队列。18岁或以上有重度抑郁发作和肥胖的成年人被分为两组:1)安非他酮暴露组和2)SSRIs暴露组。排除在指数事件之前有抗抑郁药物暴露的患者。两个队列基于16个协变量进行倾向匹配。主要结局是重度抑郁发作的缓解。次要结果包括评估各组之间的社会经济和社会心理差异。每个队列有165629名患者。主要终点分析显示,安非他酮的绝对风险率为8.5%,而SSRI组的绝对风险率为7.9%(风险比[RR] 1.07, 95% CI 1.05-1.10, p
{"title":"Remission outcomes with bupropion versus selective serotonin reuptake inhibitors in major depressive disorder with comorbid obesity: A propensity-matched cohort analysis.","authors":"Farah Khorassani, Justin Schneider, Jonathan Prunean, Gemma Espejo","doi":"10.1016/j.jad.2026.122398","DOIUrl":"10.1016/j.jad.2026.122398","url":null,"abstract":"<p><p>Observational and secondary analyses of clinical trials evaluating efficacy of antidepressants suggest that medications with noradrenergic and dopaminergic mechanisms of action may be more effective in managing symptoms of major depressive disorder (MDD) in obese patients than medications that are purely serotonergic. The purpose of this study is to compare the efficacy of bupropion versus SSRIs in patients without a documented antidepressant trial with comorbid MDD and obesity. This was a retrospective, propensity-score matched, observational study utilizing a global cohort within the TriNetX database. Adults aged 18 or over with a major depressive episode and obesity were grouped into two cohorts: 1) exposure to bupropion and 2) exposure to SSRIs. Patients with antidepressant exposure prior to the index event were excluded. Both cohorts were propensity matched based on 16 covariates. The primary outcome was remission of a major depressive episode. Secondary outcomes included evaluating socioeconomic and psychosocial differences between the groups. Each cohort yielded 165,629 patients. The primary endpoint analysis indicated a small but statistically significant difference in MDD remission rates in favor of bupropion with an absolute risk rate of 8.5% compared to 7.9% in the SSRI group (Risk Ratio [RR] 1.07, 95% CI 1.05-1.10, p < 0.0001). Binary outcomes were summarized using risk differences and risk ratios and compared between cohorts using chi-square tests. Our findings suggest bupropion monotherapy was associated with a small but statistically significant higher remission rate compared with SSRIs but further prospective studies using objective remission indicators are needed.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":" ","pages":"122398"},"PeriodicalIF":5.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148793373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nocturnal sleep-related scratching disorder as a possible variant of NREM arousal disorder: Clinical features and polysomnographic study of four newly reported cases 夜间睡眠相关的抓挠障碍可能是NREM唤醒障碍的一种变体:四例新报告病例的临床特征和多导睡眠图研究
Q1 Medicine Pub Date : 2026-12-01 Epub Date: 2025-12-02 DOI: 10.1016/j.sleepx.2025.100168
María Fernanda Gómez Morales , Nicole Cresp Sinning , Carlos H. Schenck
A clinical variant of NREM arousal disorder is described manifesting with predominantly injurious, and exclusively sleep-related scratching without any conscious awareness, and without a history of dermatologic disease. Four patients were clinically evaluated and underwent videopolysomnography (vPSG). Case 1, a 30-year-old woman had a 20-yr history of non-injurious arm scratching/rubbing during sleep. vPSG: forearm rubbing against the chin during N2/N3. Two years later she developed restless bladder symptoms and leg movements before sleep onset. Serum ferritin level: 20.7 Intravenous iron therapy resulted in full control of bedtime leg movements, restless bladder symptoms, and nocturnal scratching. Case 2, a 28-year-old married man had a 1.5-yr history of perianal scratching with excoriations/bleeding during sleep, without other parasomnia. Medical and dermatologic evaluations were negative. vPSG: arousal index of 34/hr, with multiple episodes of perianal scratching. Paroxetine, 20 mg with clonazepam as (0.5–1.0 mg) at bedtime induced 50 % efficacy. Case 3, a 26-year-old African-American female had NREM parasomnias, vigorous sleep-related scratching with keloid formation, and major depression. Medical history was negative. vPSG: arousal index: 28/hr, without abnormal behaviors. Multiple sleep latency test (MSLT): mean sleep latency, 3.6 min, no REM sleep. Idiopathic hypersomnia and NREM parasomnias were diagnosed. Sleep-related scratching and NREM parasomnias responded fully to bedtime clonazepam, 0.5 mg. Case 4, a 50-year-old female had longstanding injurious sleep-related scratching, sleep terrors, and sleep bruxism. vPSG: 55 % sleep efficiency; arousal index: 25/hr, without abnormal behaviors or apneas. MSLT: no objective sleepiness. These cases of sleep-related scratching disorder represent a heterogeneous presumed variant of NREM arousal disorder with various comorbidities, and with full/partial control from diverse therapies.
非快速眼动唤醒障碍的一种临床变体被描述为主要表现为伤害性,并且完全与睡眠有关,没有任何有意识的意识,没有皮肤疾病史。4例患者进行了临床评估并进行了视频多导睡眠描记术(vPSG)。病例1,一名30岁女性,有20年的无损伤性睡眠时抓挠/摩擦手臂的病史。vPSG:在N2/N3期间,前臂摩擦下巴。两年后,她出现了不宁膀胱症状和入睡前的腿部运动。血清铁蛋白水平:20.7静脉铁治疗可完全控制睡前腿部活动、不宁膀胱症状和夜间抓挠。病例2,28岁已婚男性,有1.5年的肛周抓挠伴睡梦中擦伤/出血病史,无其他睡眠异常。医学和皮肤评估呈阴性。vPSG:觉醒指数34/小时,伴有多次肛周抓挠。帕罗西汀20 mg与氯硝西泮(0.5 ~ 1.0 mg)睡前服用,有效率50%。病例3,一名26岁的非裔美国女性患有非快速眼动睡眠异常,伴有瘢痕疙瘩形成的剧烈睡眠抓挠和重度抑郁症。病史为阴性。vPSG:觉醒指数:28/hr,无异常行为。多次睡眠潜伏期试验(MSLT):平均睡眠潜伏期3.6 min,无REM睡眠。诊断为特发性嗜睡和非快速眼动睡眠异常。睡眠相关的抓挠和非快速眼动睡眠异常对睡前0.5毫克氯硝西泮有充分反应。病例4,一名50岁的女性长期患有与睡眠有关的伤害性抓挠,睡眠恐惧和睡眠磨牙症。vPSG: 55%的睡眠效率;觉醒指数:25/hr,无异常行为及呼吸暂停。没有客观的困倦。这些与睡眠相关的抓挠障碍的病例代表了非快速眼动唤醒障碍的异质变体,具有各种合并症,并通过各种治疗方法得到完全/部分控制。
{"title":"Nocturnal sleep-related scratching disorder as a possible variant of NREM arousal disorder: Clinical features and polysomnographic study of four newly reported cases","authors":"María Fernanda Gómez Morales ,&nbsp;Nicole Cresp Sinning ,&nbsp;Carlos H. Schenck","doi":"10.1016/j.sleepx.2025.100168","DOIUrl":"10.1016/j.sleepx.2025.100168","url":null,"abstract":"<div><div>A clinical variant of NREM arousal disorder is described manifesting with predominantly injurious, and exclusively sleep-related scratching without any conscious awareness, and without a history of dermatologic disease. Four patients were clinically evaluated and underwent videopolysomnography (vPSG). Case 1, a 30-year-old woman had a 20-yr history of non-injurious arm scratching/rubbing during sleep. vPSG: forearm rubbing against the chin during N2/N3. Two years later she developed restless bladder symptoms and leg movements before sleep onset. Serum ferritin level: 20.7 Intravenous iron therapy resulted in full control of bedtime leg movements, restless bladder symptoms, and nocturnal scratching. Case 2, a 28-year-old married man had a 1.5-yr history of perianal scratching with excoriations/bleeding during sleep, without other parasomnia. Medical and dermatologic evaluations were negative. vPSG: arousal index of 34/hr, with multiple episodes of perianal scratching. Paroxetine, 20 mg with clonazepam as (0.5–1.0 mg) at bedtime induced 50 % efficacy. Case 3, a 26-year-old African-American female had NREM parasomnias, vigorous sleep-related scratching with keloid formation, and major depression. Medical history was negative. vPSG: arousal index: 28/hr, without abnormal behaviors. Multiple sleep latency test (MSLT): mean sleep latency, 3.6 min, no REM sleep. Idiopathic hypersomnia and NREM parasomnias were diagnosed. Sleep-related scratching and NREM parasomnias responded fully to bedtime clonazepam, 0.5 mg. Case 4, a 50-year-old female had longstanding injurious sleep-related scratching, sleep terrors, and sleep bruxism. vPSG: 55 % sleep efficiency; arousal index: 25/hr, without abnormal behaviors or apneas. MSLT: no objective sleepiness. These cases of sleep-related scratching disorder represent a heterogeneous presumed variant of NREM arousal disorder with various comorbidities, and with full/partial control from diverse therapies.</div></div>","PeriodicalId":37065,"journal":{"name":"Sleep Medicine: X","volume":"11 ","pages":"Article 100168"},"PeriodicalIF":0.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145798229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Construction of phosphorus and cobalt co-modified tubular carbon nitride with dual reaction sites for boosted imidacloprid degradation. 磷钴共改性管状氮化碳双反应位点的构建促进吡虫啉的降解。
IF 9.6 1区 化学 Q1 CHEMISTRY, PHYSICAL Pub Date : 2026-12-01 Epub Date: 2026-06-24 DOI: 10.1016/j.jcis.2026.140997
Binyuan Chen, Hao Zeng, Ben Zhang, Jin Zheng, Ling Li, Zhanpeng Zhou, Rongdi Tang, Yaocheng Deng

Polymeric carbon nitride demonstrates considerable potential for the degradation of imidacloprid (IMI) in aquatic environments; however, its practical application is limited by a scarcity of active sites and the rapid recombination of photogenerated charge carriers. To address these limitations, a phosphorus (P) and cobalt (Co) co-modified tubular carbon nitride photocatalyst (Co-PTCN) with dual reaction sites was successfully synthesized. This catalyst achieved 90% removal of IMI within one hour under visible light irradiation at pH 7.5. Comprehensive characterization confirmed that the tubular morphology promotes the formation of dual reaction sites, wherein Co sites functioning as oxidation centers and P sites serving as oxygen activation and reduction centers. The enhanced separation efficiency of photogenerated charge carriers was corroborated by theoretical calculations and transient photovoltage measurements. Proposed degradation pathways of IMI were elucidated, and toxicity predictions indicated a decreasing trend in toxicity throughout the degradation process. This work provides new perspectives for feasibly constructing dual-reaction-site photocatalysts and offers theoretical support for the degradation mechanisms of IMI.

聚合物氮化碳在水生环境中具有降解吡虫啉(IMI)的巨大潜力;然而,它的实际应用受到活性位点的缺乏和光生电荷载流子的快速重组的限制。为了解决这些限制,成功合成了具有双反应位点的磷(P)和钴(Co)共改性管状氮化碳光催化剂(Co- ptcn)。在pH为7.5的可见光照射下,该催化剂在1小时内脱除了90%的IMI。综合表征证实管状结构促进了双反应位点的形成,其中Co位点作为氧化中心,P位点作为氧活化和还原中心。理论计算和瞬态光电压测量证实了光生载流子分离效率的提高。阐明了IMI的降解途径,毒性预测表明在整个降解过程中毒性呈下降趋势。本研究为构建双反应现场光催化剂的可行性提供了新的视角,并为IMI降解机理提供了理论支持。
{"title":"Construction of phosphorus and cobalt co-modified tubular carbon nitride with dual reaction sites for boosted imidacloprid degradation.","authors":"Binyuan Chen, Hao Zeng, Ben Zhang, Jin Zheng, Ling Li, Zhanpeng Zhou, Rongdi Tang, Yaocheng Deng","doi":"10.1016/j.jcis.2026.140997","DOIUrl":"10.1016/j.jcis.2026.140997","url":null,"abstract":"<p><p>Polymeric carbon nitride demonstrates considerable potential for the degradation of imidacloprid (IMI) in aquatic environments; however, its practical application is limited by a scarcity of active sites and the rapid recombination of photogenerated charge carriers. To address these limitations, a phosphorus (P) and cobalt (Co) co-modified tubular carbon nitride photocatalyst (Co-PTCN) with dual reaction sites was successfully synthesized. This catalyst achieved 90% removal of IMI within one hour under visible light irradiation at pH 7.5. Comprehensive characterization confirmed that the tubular morphology promotes the formation of dual reaction sites, wherein Co sites functioning as oxidation centers and P sites serving as oxygen activation and reduction centers. The enhanced separation efficiency of photogenerated charge carriers was corroborated by theoretical calculations and transient photovoltage measurements. Proposed degradation pathways of IMI were elucidated, and toxicity predictions indicated a decreasing trend in toxicity throughout the degradation process. This work provides new perspectives for feasibly constructing dual-reaction-site photocatalysts and offers theoretical support for the degradation mechanisms of IMI.</p>","PeriodicalId":351,"journal":{"name":"Journal of Colloid and Interface Science","volume":"723 ","pages":"140997"},"PeriodicalIF":9.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148315063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posttraumatic stress disorder and depression trends from 2001 to 2021 among post-9/11 veterans in the U.S. Millennium Cohort Study. 美国千禧年队列研究中911后退伍军人2001 - 2021年创伤后应激障碍和抑郁趋势
IF 5.7 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-12-01 Epub Date: 2026-07-31 DOI: 10.1016/j.jad.2026.122338
Judith Harbertson, Cynthia A LeardMann, Toni Rose T Geronimo-Hara, Isabel G Jacobson, Felicia R Carey, Crystal L Lewis, Neika Sharifian, Sheila F Castañeda, Erin L Richard, Nicole Riedel, Aaron I Schneiderman, Edward J Boyko, Rudolph P Rull

Approximately one in five veterans may develop a mental health condition, though longitudinal prevalence estimates among post-9/11 veterans are limited. This study examined two decades (2001-21) of posttraumatic stress disorder (PTSD) and depression data from the Millennium Cohort Study. Eligible participants were actively serving at baseline and separated before the 2019-21 follow-up survey (n = 133,575). Probable PTSD (PTSD Checklist) and depression (Patient Health Questionnaire) were assessed. Age- and sex-standardized prevalence estimates for PTSD, depression, and co-occurring PTSD/depression (a four-level, mutually exclusive variable) were calculated for six time points. PTSD increased approximately five-fold (5.2 to 25.2 cases/100 persons) and depression four-fold (3.6 to 15.5 cases/100 persons). For the co-occurring PTSD/depression outcome, a two-fold increase was observed for depression only (1.5 to 2.7 cases/100 persons), while increases for PTSD only (3.1 to 12.4 cases/100 persons), and comorbid PTSD/depression (2.0 to 12.7 cases/100 persons) were four- and six-fold, respectively. In this population-based study, prevalence estimates of PTSD and depression increased over time, with larger increases attributable to PTSD and co-occurring PTSD/depression. These pronounced increases in prevalence estimates warrant consideration for expansion of mental health screening and treatment services among post-9/11 veterans.

大约五分之一的退伍军人可能会出现心理健康问题,尽管对9/11后退伍军人的纵向患病率估计有限。这项研究调查了20年来(2001-21年)来自千年队列研究的创伤后应激障碍(PTSD)和抑郁症的数据。符合条件的参与者在基线时积极服务,并在2019-21年随访调查前分开(n = 133,575)。对可能的PTSD (PTSD检查表)和抑郁(患者健康问卷)进行评估。年龄和性别标准化的PTSD、抑郁症和共病PTSD/抑郁症(一个4级、互斥变量)的患病率估计计算了6个时间点。PTSD增加了大约5倍(5.2至25.2例/100人),抑郁症增加了4倍(3.6至15.5例/100人)。对于同时发生的PTSD/抑郁症结果,仅抑郁症增加了两倍(1.5至2.7例/100人),而PTSD仅增加了(3.1至12.4例/100人),而合并PTSD/抑郁症(2.0至12.7例/100人)分别增加了4倍和6倍。在这项以人群为基础的研究中,PTSD和抑郁症的患病率估计随着时间的推移而增加,其中较大的增加可归因于PTSD和共存的PTSD/抑郁症。这些流行率的显著增加值得考虑在9/11后退伍军人中扩大心理健康检查和治疗服务。
{"title":"Posttraumatic stress disorder and depression trends from 2001 to 2021 among post-9/11 veterans in the U.S. Millennium Cohort Study.","authors":"Judith Harbertson, Cynthia A LeardMann, Toni Rose T Geronimo-Hara, Isabel G Jacobson, Felicia R Carey, Crystal L Lewis, Neika Sharifian, Sheila F Castañeda, Erin L Richard, Nicole Riedel, Aaron I Schneiderman, Edward J Boyko, Rudolph P Rull","doi":"10.1016/j.jad.2026.122338","DOIUrl":"10.1016/j.jad.2026.122338","url":null,"abstract":"<p><p>Approximately one in five veterans may develop a mental health condition, though longitudinal prevalence estimates among post-9/11 veterans are limited. This study examined two decades (2001-21) of posttraumatic stress disorder (PTSD) and depression data from the Millennium Cohort Study. Eligible participants were actively serving at baseline and separated before the 2019-21 follow-up survey (n = 133,575). Probable PTSD (PTSD Checklist) and depression (Patient Health Questionnaire) were assessed. Age- and sex-standardized prevalence estimates for PTSD, depression, and co-occurring PTSD/depression (a four-level, mutually exclusive variable) were calculated for six time points. PTSD increased approximately five-fold (5.2 to 25.2 cases/100 persons) and depression four-fold (3.6 to 15.5 cases/100 persons). For the co-occurring PTSD/depression outcome, a two-fold increase was observed for depression only (1.5 to 2.7 cases/100 persons), while increases for PTSD only (3.1 to 12.4 cases/100 persons), and comorbid PTSD/depression (2.0 to 12.7 cases/100 persons) were four- and six-fold, respectively. In this population-based study, prevalence estimates of PTSD and depression increased over time, with larger increases attributable to PTSD and co-occurring PTSD/depression. These pronounced increases in prevalence estimates warrant consideration for expansion of mental health screening and treatment services among post-9/11 veterans.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":" ","pages":"122338"},"PeriodicalIF":5.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148648508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging brain structures and adolescent depression and anxiety symptoms: A symptom-oriented approach. 连接大脑结构与青少年抑郁和焦虑症状:以症状为导向的方法。
IF 5.7 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-12-01 Epub Date: 2026-08-18 DOI: 10.1016/j.jad.2026.122396
Qingwen Ding, Divyangana Rakesh, Siya Peng, Xinying Li, Sarah Whittle

Background: Anxiety and depression show substantial heterogeneity and often emerge in adolescence. However, their brain structural associations from a symptom-oriented perspective remain unclear. This study investigated the symptom structures of adolescent anxiety and depression and identified key brain regions linking brain structure to symptoms.

Methods: A total of 1568 adolescents with elevated depressive symptoms and 413 adolescents with elevated anxiety symptoms were identified from the Adolescent Brain Cognitive Development study. Participants completed symptom assessments and underwent Magnetic Resonance Imaging scanning. A total of ten symptom-only networks and symptom-brain networks were constructed to identify the central symptoms and the key brain structure associated with depression and anxiety symptoms.

Results: In the symptom-only networks, concentration difficulties emerged as the shared central symptom, while self-hatred and irritability were the unique central symptoms for depression and anxiety, respectively. In the symptom-brain networks, left- and right-pallidum volumes exhibited the highest bridge centrality in connection with depressive symptoms, whereas left-nucleus accumbens volume showed the highest bridge centrality in connection with anxiety symptoms. Cortical structures showed sparse connections with both depressive and anxiety symptoms.

Conclusion: Our findings highlight the pallidum and nucleus accumbens as key brain regions linking brain structure to adolescent depressive and anxiety symptoms. These results provide insights into the neural mechanisms of depression and anxiety from a symptom-oriented perspective and may inform targeted interventions for at-risk youth.

背景:焦虑和抑郁表现出很大的异质性,通常出现在青春期。然而,从症状导向的角度来看,他们的大脑结构关联仍然不清楚。本研究调查了青少年焦虑和抑郁的症状结构,并确定了将大脑结构与症状联系起来的关键大脑区域。方法:从青少年大脑认知发展研究中鉴定出1568名抑郁症状升高的青少年和413名焦虑症状升高的青少年。参与者完成症状评估并接受磁共振成像扫描。共构建10个症状网络和症状脑网络,以确定与抑郁和焦虑症状相关的中心症状和关键脑结构。结果:在无症状网络中,注意力集中困难是共同的中心症状,而自我憎恨和易怒分别是抑郁和焦虑的独特中心症状。在症状-脑网络中,与抑郁症状相关的左、右苍白球体积桥中心性最高,而与焦虑症状相关的左伏隔核体积桥中心性最高。大脑皮层结构与抑郁和焦虑症状均有稀疏的联系。结论:我们的研究结果强调了苍白质和伏隔核是连接大脑结构与青少年抑郁和焦虑症状的关键大脑区域。这些结果从症状导向的角度深入了解抑郁和焦虑的神经机制,并可能为高危青少年提供有针对性的干预措施。
{"title":"Bridging brain structures and adolescent depression and anxiety symptoms: A symptom-oriented approach.","authors":"Qingwen Ding, Divyangana Rakesh, Siya Peng, Xinying Li, Sarah Whittle","doi":"10.1016/j.jad.2026.122396","DOIUrl":"10.1016/j.jad.2026.122396","url":null,"abstract":"<p><strong>Background: </strong>Anxiety and depression show substantial heterogeneity and often emerge in adolescence. However, their brain structural associations from a symptom-oriented perspective remain unclear. This study investigated the symptom structures of adolescent anxiety and depression and identified key brain regions linking brain structure to symptoms.</p><p><strong>Methods: </strong>A total of 1568 adolescents with elevated depressive symptoms and 413 adolescents with elevated anxiety symptoms were identified from the Adolescent Brain Cognitive Development study. Participants completed symptom assessments and underwent Magnetic Resonance Imaging scanning. A total of ten symptom-only networks and symptom-brain networks were constructed to identify the central symptoms and the key brain structure associated with depression and anxiety symptoms.</p><p><strong>Results: </strong>In the symptom-only networks, concentration difficulties emerged as the shared central symptom, while self-hatred and irritability were the unique central symptoms for depression and anxiety, respectively. In the symptom-brain networks, left- and right-pallidum volumes exhibited the highest bridge centrality in connection with depressive symptoms, whereas left-nucleus accumbens volume showed the highest bridge centrality in connection with anxiety symptoms. Cortical structures showed sparse connections with both depressive and anxiety symptoms.</p><p><strong>Conclusion: </strong>Our findings highlight the pallidum and nucleus accumbens as key brain regions linking brain structure to adolescent depressive and anxiety symptoms. These results provide insights into the neural mechanisms of depression and anxiety from a symptom-oriented perspective and may inform targeted interventions for at-risk youth.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"414 ","pages":"122396"},"PeriodicalIF":5.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148793408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of health comorbidities and associated health care costs in the Australian Genetics of Depression Study using the medication-based Rx-Risk Comorbidity Index. 使用基于药物的rx风险合并症指数的澳大利亚抑郁症遗传学研究中的健康合并症负担和相关医疗保健费用
IF 5.7 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-12-01 Epub Date: 2026-08-18 DOI: 10.1016/j.jad.2026.122397
Penelope A Lind, Ian B Hickie, Enda M Byrne, Nicholas G Martin, Sarah E Medland

Depression is associated with substantial multimorbidity and elevated healthcare utilization. This study characterised treated comorbidities and healthcare costs in participants of the Australian Genetics of Depression Study (AGDS) using pharmaceutical claims data. Linked Pharmaceutical Benefits Scheme (PBS) records from 01/07/2013-31/12/2017 were available for 15,890 AGDS participants. Forty-six chronic conditions were inferred using the validated pharmacy-based Rx-Risk Comorbidity Index based on Anatomical Therapeutic Chemical Classification System codes and PBS item codes. Prevalence estimates were compared with a 4:1 matched non-depressed Australian representative population sample (10PCT) with PBS claims data available from 01/07/2010-31/12/2014. AGDS participants had a higher mean number of inferred comorbidities (4.6 ± 2.9) than individuals in the 10PCT sample (2.0 ± 2.1). Excluding depression, 89.1% of AGDS participants had at least one inferred comorbidity, most commonly pain (51.0%), inflammation/pain (40.3%), and anxiety (32.3%). Metabolic and cardiovascular conditions frequently co-occurred (13.2%). Within AGDS, comorbidity burden was higher among women and increased with age, body mass index, number of depressive episodes and symptoms, and annual healthcare costs. Median annual healthcare costs were approximately 65% higher among AGDS participants with 2-3 inferred comorbidities compared with those with none. This study provides a detailed description of treated comorbidities and associated healthcare costs among Australians living with depression. The findings highlight the substantial multimorbidity burden in this cohort and its association with increased healthcare costs to both the individual and health system.

抑郁症与大量的多病和较高的医疗保健利用率有关。本研究利用药物索赔数据,描述了澳大利亚抑郁症遗传学研究(AGDS)参与者的治疗合并症和医疗费用。从2013年7月1日至2017年12月31日,15890名AGDS参与者可获得相关药物福利计划(PBS)记录。采用基于解剖治疗化学分类系统代码和PBS项目代码的经验证的基于药物的Rx-Risk共病指数推断46种慢性疾病。患病率估计值与4:1匹配的非抑郁症澳大利亚代表性人群样本(10PCT)与2010年7月1日至2014年12月31日可获得的PBS索赔数据进行比较。AGDS参与者的平均推断共病数(4.6±2.9)高于10PCT样本中的个体(2.0±2.1)。除抑郁症外,89.1%的AGDS参与者至少有一种推断的合并症,最常见的是疼痛(51.0%),炎症/疼痛(40.3%)和焦虑(32.3%)。代谢和心血管疾病经常同时发生(13.2%)。在AGDS中,女性的合并症负担更高,并且随着年龄、体重指数、抑郁发作和症状的数量以及年度医疗费用的增加而增加。在推断有2-3种合并症的AGDS参与者中,年平均医疗费用比无合并症的参与者高出约65%。本研究详细描述了澳大利亚抑郁症患者的合并症治疗和相关医疗费用。研究结果强调了该队列中大量的多病负担及其与个人和卫生系统医疗费用增加的关联。
{"title":"Burden of health comorbidities and associated health care costs in the Australian Genetics of Depression Study using the medication-based Rx-Risk Comorbidity Index.","authors":"Penelope A Lind, Ian B Hickie, Enda M Byrne, Nicholas G Martin, Sarah E Medland","doi":"10.1016/j.jad.2026.122397","DOIUrl":"10.1016/j.jad.2026.122397","url":null,"abstract":"<p><p>Depression is associated with substantial multimorbidity and elevated healthcare utilization. This study characterised treated comorbidities and healthcare costs in participants of the Australian Genetics of Depression Study (AGDS) using pharmaceutical claims data. Linked Pharmaceutical Benefits Scheme (PBS) records from 01/07/2013-31/12/2017 were available for 15,890 AGDS participants. Forty-six chronic conditions were inferred using the validated pharmacy-based Rx-Risk Comorbidity Index based on Anatomical Therapeutic Chemical Classification System codes and PBS item codes. Prevalence estimates were compared with a 4:1 matched non-depressed Australian representative population sample (10PCT) with PBS claims data available from 01/07/2010-31/12/2014. AGDS participants had a higher mean number of inferred comorbidities (4.6 ± 2.9) than individuals in the 10PCT sample (2.0 ± 2.1). Excluding depression, 89.1% of AGDS participants had at least one inferred comorbidity, most commonly pain (51.0%), inflammation/pain (40.3%), and anxiety (32.3%). Metabolic and cardiovascular conditions frequently co-occurred (13.2%). Within AGDS, comorbidity burden was higher among women and increased with age, body mass index, number of depressive episodes and symptoms, and annual healthcare costs. Median annual healthcare costs were approximately 65% higher among AGDS participants with 2-3 inferred comorbidities compared with those with none. This study provides a detailed description of treated comorbidities and associated healthcare costs among Australians living with depression. The findings highlight the substantial multimorbidity burden in this cohort and its association with increased healthcare costs to both the individual and health system.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"414 ","pages":"122397"},"PeriodicalIF":5.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148793343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal microstructural alterations as early phenotypes of depression in radiogenomics analysis. 放射基因组学分析中视网膜显微结构改变作为抑郁症的早期表型。
IF 5.7 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-12-01 Epub Date: 2026-08-28 DOI: 10.1016/j.jad.2026.122413
Shilei Wang, Shuling Ye, Ming Feng, Zhifeng Zhou, Yuting Yang, Qinqin Zhang, KuangChing Lin, Sisi Chen, Fan Lu, Meixiao Shen, Zi Jin

Background: With the increasing prevalence of depression, there is an urgent clinical need for early screening in depression. The retina offers a promising window for early screening in depression due to its rapid, non-invasive, objective, eye-brain correlated characteristics, but previous research has yielded conflicting alterations in retinal microstructure in depression.

Methods: We screened retinal optical coherence tomography and brain magnetic resonance imaging data in the UK Biobank to enroll 23,225 participants for retinal study of depression occurrence, and 1475 participants for the eye-brain association study. We also used genetic data (ID: ebi-a-GCST90014267 and ukb-d-20,448) from the Integrative Epidemiology Unit Open Genome-Wide Association Study for Mendelian randomization analysis. We used Cox regression to assess the association between retinal microstructure and depression risk, Mendelian randomization to infer causality, and mediation analysis to explore retina-brain pathway association.

Results: The Cox regression analysis showed that retinal ganglion cell-inner plexiform layer (GCIPL) thickness remained a significant predictor of depression. The Mendelian randomization analysis indicated a positive statistical association between GCIPL thickness and depression. Moreover, there was a significant positive correlation (all p < 0.001) between the volume of specific depression-related brain regions and the GCIPL thickness. Adjusting for age, sex, and head size, the mediation analysis provided preliminary evidence for a potential anatomical pathway linking retinal GCIPL thickness to depression-related brain regions through primary visual cortex and secondary visual cortex volumes.

Conclusion: Thickened retinal GCIPL is a potential early phenotype of depression and has a potential association pathway with depression-related brain regions using a radiogenomics approach.

背景:随着抑郁症患病率的增加,临床迫切需要对抑郁症进行早期筛查。视网膜因其快速、非侵入性、客观、眼-脑相关的特征,为抑郁症的早期筛查提供了一个有希望的窗口,但之前的研究已经得出了抑郁症视网膜微观结构的相互矛盾的改变。方法:我们筛选英国生物银行的视网膜光学相干断层扫描和脑磁共振成像数据,招募23,225名受试者进行抑郁症发生的视网膜研究,1475名受试者进行眼脑关联研究。我们还使用来自综合流行病学单位开放全基因组关联研究的遗传数据(ID: ebi-a-GCST90014267和ukb-d-20,448)进行孟德尔随机化分析。我们使用Cox回归来评估视网膜微观结构与抑郁风险之间的关系,孟德尔随机化来推断因果关系,中介分析来探索视网膜-脑通路的关联。结果:Cox回归分析显示,视网膜神经节细胞-内丛状层(GCIPL)厚度仍然是抑郁症的显著预测因子。孟德尔随机化分析显示GCIPL厚度与抑郁呈正相关。结论:利用放射基因组学方法,视网膜GCIPL增厚是抑郁症的一种潜在早期表型,并且与抑郁症相关的脑区有潜在的关联途径。
{"title":"Retinal microstructural alterations as early phenotypes of depression in radiogenomics analysis.","authors":"Shilei Wang, Shuling Ye, Ming Feng, Zhifeng Zhou, Yuting Yang, Qinqin Zhang, KuangChing Lin, Sisi Chen, Fan Lu, Meixiao Shen, Zi Jin","doi":"10.1016/j.jad.2026.122413","DOIUrl":"10.1016/j.jad.2026.122413","url":null,"abstract":"<p><strong>Background: </strong>With the increasing prevalence of depression, there is an urgent clinical need for early screening in depression. The retina offers a promising window for early screening in depression due to its rapid, non-invasive, objective, eye-brain correlated characteristics, but previous research has yielded conflicting alterations in retinal microstructure in depression.</p><p><strong>Methods: </strong>We screened retinal optical coherence tomography and brain magnetic resonance imaging data in the UK Biobank to enroll 23,225 participants for retinal study of depression occurrence, and 1475 participants for the eye-brain association study. We also used genetic data (ID: ebi-a-GCST90014267 and ukb-d-20,448) from the Integrative Epidemiology Unit Open Genome-Wide Association Study for Mendelian randomization analysis. We used Cox regression to assess the association between retinal microstructure and depression risk, Mendelian randomization to infer causality, and mediation analysis to explore retina-brain pathway association.</p><p><strong>Results: </strong>The Cox regression analysis showed that retinal ganglion cell-inner plexiform layer (GCIPL) thickness remained a significant predictor of depression. The Mendelian randomization analysis indicated a positive statistical association between GCIPL thickness and depression. Moreover, there was a significant positive correlation (all p < 0.001) between the volume of specific depression-related brain regions and the GCIPL thickness. Adjusting for age, sex, and head size, the mediation analysis provided preliminary evidence for a potential anatomical pathway linking retinal GCIPL thickness to depression-related brain regions through primary visual cortex and secondary visual cortex volumes.</p><p><strong>Conclusion: </strong>Thickened retinal GCIPL is a potential early phenotype of depression and has a potential association pathway with depression-related brain regions using a radiogenomics approach.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":" ","pages":"122413"},"PeriodicalIF":5.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148812856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual-substrate-based full-color fluorescent probe TPE-4PA@Tb/Eu-GMP-acac ICPs for alkaline phosphatase detection and its on-site application for algal bloom alert. 双底物全彩荧光探针TPE-4PA@Tb/Eu-GMP-acac ICPs检测碱性磷酸酶及其在藻华预警中的现场应用
IF 6.7 1区 化学 Q1 CHEMISTRY, ANALYTICAL Pub Date : 2026-12-01 Epub Date: 2026-06-19 DOI: 10.1016/j.talanta.2026.130159
Yuanyue Wu, Chunqian Yu, Yiwen Min, Changshun Chen, Ke Zhou, Wanying Zhai, Tianshu Zhou, Jingjing Deng

The development of rapid, on-site analytical methods and test strips for alkaline phosphatase activity (APA) is crucial for addressing drinking water safety crises, as it enables eutrophication assessment and algal bloom warnings under phosphorus-limited conditions. In this study, we incorporate aggregation-induced emission luminogen (AIEgen) guest TPE-4PA into bimetallic lanthanide-based infinite coordination polymers (Tb/Eu-GMP ICPs). TPE-4PA exhibits unprecedented binding preference for Tb3+ over Eu3+, triggering coordination-induced emission (CIE) at 450 nm and modulating the antenna effect (AE) and the tandem energy transfer (TER) from Tb3+ to Eu3+. Subsequently, acetylacetone (acac) was further introduced to yield TPE-4PA@Tb/Eu-GMP-acac ICPs with an appropriate full-color fluoresce response capability. The addition of alkaline phosphatase (ALP) hydrolyzes GMP and TPE-4PA dual substrates, resulting in reduced characteristic emission of the bimetallic Ln-ICP host at 493, 548, 593, 619 and 703 nm, increased monomer emission of TPE-4PA at 392 nm, as well as the solvent-driven AIE of the enzymatic product TPE-4OH at 430 nm, which constitutes a novel ratiometric ALP sensing mechanism with pale-purple to blue fluorescence color shifts. Featuring high sensitivity, doubly assured selectivity, and operational simplicity, this "all-in-one" probe enables real-time APA monitoring via dual-substrate kinetics and is suitable for on-site ALP test strip development. Moreover, the unique color transition point of the dual-substrate-based TPE-4PA@Tb/Eu-GMP-acac ICPs probe can be designed to signal an APA surge prior to algal bloom onset, which holds significant potential for the development of microalgae pollution early-warning systems, thereby safeguarding drinking water safety.

开发快速的现场碱性磷酸酶活性(APA)分析方法和试纸对于解决饮用水安全危机至关重要,因为它可以在限磷条件下进行富营养化评估和藻华预警。在这项研究中,我们将聚集诱导发光原(AIEgen)客体TPE-4PA加入到双金属镧系无限配位聚合物(Tb/Eu-GMP icp)中。TPE-4PA对Tb3+表现出前所未有的结合偏好,在450 nm处触发协调诱导发射(CIE),并调节天线效应(AE)和从Tb3+到Eu3+的串联能量转移(TER)。随后,进一步引入乙酰丙酮(acac),得到TPE-4PA@Tb/Eu-GMP-acac icp,具有适当的全色荧光响应能力。碱性磷酸酶(ALP)的加入可水解GMP和TPE-4PA双底物,导致双金属Ln-ICP主体在493、548、593、619和703 nm处的特征发射降低,TPE-4PA在392 nm处的单体发射增加,酶产物TPE-4OH在430 nm处的溶剂驱动AIE增加,构成了一种新的比例ALP传感机制,荧光色由淡紫色向蓝色偏移。这种“一体化”探针具有高灵敏度,双重保证选择性和操作简单性,可以通过双底物动力学实时监测APA,适用于现场ALP试纸开发。此外,基于双底物TPE-4PA@Tb/Eu-GMP-acac的icp探针具有独特的颜色过渡点,可设计用于在藻华发生之前发出APA激增的信号,这对于开发微藻污染预警系统具有重要的潜力,从而保障饮用水安全。
{"title":"Dual-substrate-based full-color fluorescent probe TPE-4PA@Tb/Eu-GMP-acac ICPs for alkaline phosphatase detection and its on-site application for algal bloom alert.","authors":"Yuanyue Wu, Chunqian Yu, Yiwen Min, Changshun Chen, Ke Zhou, Wanying Zhai, Tianshu Zhou, Jingjing Deng","doi":"10.1016/j.talanta.2026.130159","DOIUrl":"10.1016/j.talanta.2026.130159","url":null,"abstract":"<p><p>The development of rapid, on-site analytical methods and test strips for alkaline phosphatase activity (APA) is crucial for addressing drinking water safety crises, as it enables eutrophication assessment and algal bloom warnings under phosphorus-limited conditions. In this study, we incorporate aggregation-induced emission luminogen (AIEgen) guest TPE-4PA into bimetallic lanthanide-based infinite coordination polymers (Tb/Eu-GMP ICPs). TPE-4PA exhibits unprecedented binding preference for Tb<sup>3+</sup> over Eu<sup>3+</sup>, triggering coordination-induced emission (CIE) at 450 nm and modulating the antenna effect (AE) and the tandem energy transfer (TER) from Tb<sup>3+</sup> to Eu<sup>3+</sup>. Subsequently, acetylacetone (acac) was further introduced to yield TPE-4PA@Tb/Eu-GMP-acac ICPs with an appropriate full-color fluoresce response capability. The addition of alkaline phosphatase (ALP) hydrolyzes GMP and TPE-4PA dual substrates, resulting in reduced characteristic emission of the bimetallic Ln-ICP host at 493, 548, 593, 619 and 703 nm, increased monomer emission of TPE-4PA at 392 nm, as well as the solvent-driven AIE of the enzymatic product TPE-4OH at 430 nm, which constitutes a novel ratiometric ALP sensing mechanism with pale-purple to blue fluorescence color shifts. Featuring high sensitivity, doubly assured selectivity, and operational simplicity, this \"all-in-one\" probe enables real-time APA monitoring via dual-substrate kinetics and is suitable for on-site ALP test strip development. Moreover, the unique color transition point of the dual-substrate-based TPE-4PA@Tb/Eu-GMP-acac ICPs probe can be designed to signal an APA surge prior to algal bloom onset, which holds significant potential for the development of microalgae pollution early-warning systems, thereby safeguarding drinking water safety.</p>","PeriodicalId":435,"journal":{"name":"Talanta","volume":"310 ","pages":"130159"},"PeriodicalIF":6.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148300521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferrous iron-induced secondary mineral formation regulates organic carbon bioavailability and methane recovery from iron-enhanced primary sludge. 亚铁诱导的次生矿物形成调节有机碳生物利用度和铁强化初级污泥的甲烷回收。
IF 8.2 1区 环境科学与生态学 Q1 AGRICULTURAL ENGINEERING Pub Date : 2026-12-01 Epub Date: 2026-08-15 DOI: 10.1016/j.biortech.2026.135638
Feifei Chu, Fangmei Cheng, Xiaomeng Zhang, Liyan Wei, Xinhou Zhang, Yun Chen, Lei Zhao, Fei Yang, Nan Shen

Iron salt-based chemically enhanced primary treatment effectively captures organic carbon from municipal wastewater, providing a concentrated substrate for methane recovery through anaerobic digestion. However, methane production from iron salt-based chemically enhanced primary sedimentation (Fe-CEPS) sludge remains substantially lower than expected, and the mechanisms responsible for this reduction remain poorly understood. Here, the relationship between iron-bound organic carbon (Fe-OC) formation and methane production was investigated by combining anaerobic digestion experiments with iron mineral-glucose model systems. Increasing Fe dosage reduced methane yield from 221.1 to 74.7 mL CH4 g-1 VS while promoting Fe-OC accumulation. A strong negative correlation was observed between Fe-OC content and methane production. Fresh Fe-CEPS sludge contained only limited Fe-OC (<10% of total organic carbon), whereas Fe-OC accounted for approximately 26% of total organic carbon after anaerobic digestion, indicating that Fe-OC formed predominantly during digestion rather than during coagulation. Iron speciation analyses revealed extensive Fe(III) reduction accompanied by secondary iron mineral formation. Model experiments further demonstrated that Fe(II)-induced mineral transformation increased mineral crystallinity, enhanced organic carbon stabilization, reduced carbon bioavailability, and consequently suppressed methane production. Scanning electron microscopy coupled with energy-dispersive X-ray spectroscopy further revealed progressively stronger spatial associations between organic carbon and iron minerals as mineral crystallinity increased. These findings reveal a previously unrecognized mechanism whereby Fe(II)-induced secondary iron mineral formation promotes Fe-OC accumulation and reduces organic carbon bioavailability during anaerobic digestion. Regulating iron mineral transformation may therefore represent an effective strategy for improving methane recovery from iron-enhanced primary sludge.

铁盐基化学强化一级处理可有效捕获城市污水中的有机碳,通过厌氧消化为甲烷回收提供浓缩基质。然而,铁盐基化学强化初级沉积(Fe-CEPS)污泥的甲烷产量仍然大大低于预期,并且对这种减少的机制仍然知之甚少。本文通过厌氧消化实验和铁矿物-葡萄糖模型系统相结合,研究了铁结合有机碳(Fe-OC)形成与甲烷产量的关系。增加铁投加量使甲烷产率从221.1降低到74.7 mL CH4 g-1 VS,同时促进了Fe- oc的积累。Fe-OC含量与甲烷产量呈显著负相关。新鲜Fe-CEPS污泥只含有有限的Fe-OC (
{"title":"Ferrous iron-induced secondary mineral formation regulates organic carbon bioavailability and methane recovery from iron-enhanced primary sludge.","authors":"Feifei Chu, Fangmei Cheng, Xiaomeng Zhang, Liyan Wei, Xinhou Zhang, Yun Chen, Lei Zhao, Fei Yang, Nan Shen","doi":"10.1016/j.biortech.2026.135638","DOIUrl":"10.1016/j.biortech.2026.135638","url":null,"abstract":"<p><p>Iron salt-based chemically enhanced primary treatment effectively captures organic carbon from municipal wastewater, providing a concentrated substrate for methane recovery through anaerobic digestion. However, methane production from iron salt-based chemically enhanced primary sedimentation (Fe-CEPS) sludge remains substantially lower than expected, and the mechanisms responsible for this reduction remain poorly understood. Here, the relationship between iron-bound organic carbon (Fe-OC) formation and methane production was investigated by combining anaerobic digestion experiments with iron mineral-glucose model systems. Increasing Fe dosage reduced methane yield from 221.1 to 74.7 mL CH<sub>4</sub> g<sup>-1</sup> VS while promoting Fe-OC accumulation. A strong negative correlation was observed between Fe-OC content and methane production. Fresh Fe-CEPS sludge contained only limited Fe-OC (<10% of total organic carbon), whereas Fe-OC accounted for approximately 26% of total organic carbon after anaerobic digestion, indicating that Fe-OC formed predominantly during digestion rather than during coagulation. Iron speciation analyses revealed extensive Fe(III) reduction accompanied by secondary iron mineral formation. Model experiments further demonstrated that Fe(II)-induced mineral transformation increased mineral crystallinity, enhanced organic carbon stabilization, reduced carbon bioavailability, and consequently suppressed methane production. Scanning electron microscopy coupled with energy-dispersive X-ray spectroscopy further revealed progressively stronger spatial associations between organic carbon and iron minerals as mineral crystallinity increased. These findings reveal a previously unrecognized mechanism whereby Fe(II)-induced secondary iron mineral formation promotes Fe-OC accumulation and reduces organic carbon bioavailability during anaerobic digestion. Regulating iron mineral transformation may therefore represent an effective strategy for improving methane recovery from iron-enhanced primary sludge.</p>","PeriodicalId":258,"journal":{"name":"Bioresource Technology","volume":" ","pages":"135638"},"PeriodicalIF":8.2,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148757002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1